3,4-dihydroxyphenylacetic acid has been researched along with Cognition Disorders in 7 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar, AS | 1 |
| Lopes, SC | 1 |
| Tristão, FS | 1 |
| Rial, D | 1 |
| de Oliveira, G | 1 |
| da Cunha, C | 1 |
| Raisman-Vozari, R | 1 |
| Prediger, RD | 1 |
| Wey, MC | 1 |
| Fernandez, E | 1 |
| Martinez, PA | 1 |
| Sullivan, P | 1 |
| Goldstein, DS | 1 |
| Strong, R | 1 |
| Pardon, MC | 1 |
| Hanoun, N | 1 |
| Perez-Diaz, F | 1 |
| Joubert, C | 1 |
| Launay, JM | 1 |
| Christen, Y | 1 |
| Hamon, M | 1 |
| Cohen-Salmon, C | 1 |
| Castner, SA | 1 |
| Vosler, PS | 1 |
| Goldman-Rakic, PS | 1 |
| Shimada, A | 1 |
| Yamaguchi, K | 1 |
| Yanagita, T | 1 |
| Heim, C | 1 |
| Zhang, J | 1 |
| Lan, J | 1 |
| Sieklucka, M | 1 |
| Kurz, T | 1 |
| Riederer, P | 1 |
| Gerlach, M | 1 |
| Sontag, KH | 1 |
| Rayevsky, KS | 1 |
| Bondarenko, NA | 1 |
| Kudrin, VS | 1 |
| Miroshnichenko, II | 1 |
7 other studies available for 3,4-dihydroxyphenylacetic acid and Cognition Disorders
| Article | Year |
|---|---|
Exercise Improves Cognitive Impairment and Dopamine Metabolism in MPTP-Treated Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catale | 2016 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; C | 2012 |
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist | 2004 |
Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Centra | 2005 |
Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Hy | 1996 |
Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Carotid Stenosis; Cognition Disorders; Corpu | 2000 |
Cognitive deficiency induced by the acute stress in rats: a possible role of brain catecholaminergic systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; | 1990 |